C4 Therapeutics, Inc.CCCCNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-5.4%
5Y CAGR+18.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-5.4%/yr
vs +56.3%/yr prior
5Y CAGR
+18.9%/yr
Recent deceleration
Acceleration
-61.8pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.20M | -14.1% |
| 2024 | $42.12M | +0.1% |
| 2023 | $42.08M | -1.7% |
| 2022 | $42.79M | +28.7% |
| 2021 | $33.25M | +118.7% |
| 2020 | $15.20M | +73.3% |
| 2019 | $8.77M | +22.5% |
| 2018 | $7.16M | - |